Initial work demonstrating a similar approach to treat the autoimmune form of PAP via macrophage transplantation, where transplanted cells are genetically modified to express GM-CSF has also recently been reported in conference proceedings145. This evidence concerns the gene CSF2 and pulmonary alveolar proteinosis.